435 related articles for article (PubMed ID: 17708366)
1. Description of patients with midgut carcinoid tumours: clinical database from a Danish centre.
Nykjaer KM; Grønbaek H; Nielsen DT; Christiansen P; Astrup LB
In Vivo; 2007; 21(4):679-84. PubMed ID: 17708366
[TBL] [Abstract][Full Text] [Related]
2. Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases.
Hellman P; Lundström T; Ohrvall U; Eriksson B; Skogseid B; Oberg K; Tiensuu Janson E; Akerström G
World J Surg; 2002 Aug; 26(8):991-7. PubMed ID: 12016480
[TBL] [Abstract][Full Text] [Related]
3. Circulating markers of prognosis and response to treatment in patients with midgut carcinoid tumours.
Turner GB; Johnston BT; McCance DR; McGinty A; Watson RG; Patterson CC; Ardill JE
Gut; 2006 Nov; 55(11):1586-91. PubMed ID: 16556667
[TBL] [Abstract][Full Text] [Related]
4. Surgical treatment as a principle in patients with advanced abdominal carcinoid tumors.
Søreide O; Berstad T; Bakka A; Schrumpf E; Hanssen LE; Engh V; Bergan A; Flatmark A
Surgery; 1992 Jan; 111(1):48-54. PubMed ID: 1728075
[TBL] [Abstract][Full Text] [Related]
5. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival.
Gupta S; Johnson MM; Murthy R; Ahrar K; Wallace MJ; Madoff DC; McRae SE; Hicks ME; Rao S; Vauthey JN; Ajani JA; Yao JC
Cancer; 2005 Oct; 104(8):1590-602. PubMed ID: 16134179
[TBL] [Abstract][Full Text] [Related]
6. Carcinoids of the jejunum and ileum: an immunohistochemical and clinicopathologic study of 167 cases.
Burke AP; Thomas RM; Elsayed AM; Sobin LH
Cancer; 1997 Mar; 79(6):1086-93. PubMed ID: 9070484
[TBL] [Abstract][Full Text] [Related]
7. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
[TBL] [Abstract][Full Text] [Related]
8. Prolonged survival after hepatic artery embolization in patients with midgut carcinoid syndrome.
Swärd C; Johanson V; Nieveen van Dijkum E; Jansson S; Nilsson O; Wängberg B; Ahlman H; Kölby L
Br J Surg; 2009 May; 96(5):517-21. PubMed ID: 19358175
[TBL] [Abstract][Full Text] [Related]
9. Endocrine tumors of the ileum: factors correlated with survival.
Tomassetti P; Campana D; Piscitelli L; Casadei R; Nori F; Brocchi E; Santini D; Pezzilli R; Corinaldesi R
Neuroendocrinology; 2006; 83(5-6):380-6. PubMed ID: 17016032
[TBL] [Abstract][Full Text] [Related]
10. Surgical treatment of peritoneal carcinomatosis from well-differentiated digestive endocrine carcinomas.
Elias D; Sideris L; Liberale G; Ducreux M; Malka D; Lasser P; Duvillard P; Baudin E
Surgery; 2005 Apr; 137(4):411-6. PubMed ID: 15800487
[TBL] [Abstract][Full Text] [Related]
11. Randomized clinical trial of the effect of interferon alpha on survival in patients with disseminated midgut carcinoid tumours.
Kölby L; Persson G; Franzén S; Ahrén B
Br J Surg; 2003 Jun; 90(6):687-93. PubMed ID: 12808615
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers predict outcomes following cytoreductive surgery for hepatic metastases from functional carcinoid tumors.
Jensen EH; Kvols L; McLoughlin JM; Lewis JM; Alvarado MD; Yeatman T; Malafa M; Shibata D
Ann Surg Oncol; 2007 Feb; 14(2):780-5. PubMed ID: 17146740
[TBL] [Abstract][Full Text] [Related]
13. Persistent low urinary excretion of 5-HIAA is a marker for favourable survival during follow-up in patients with disseminated midgut carcinoid tumours.
van der Horst-Schrivers AN; Post WJ; Kema IP; Links TP; Willemse PH; Wymenga AN; de Vries EG
Eur J Cancer; 2007 Dec; 43(18):2651-7. PubMed ID: 17825550
[TBL] [Abstract][Full Text] [Related]
14. Comparison of survival between malignant neuroendocrine tumours of midgut and pancreatic origin.
Johanson V; Tisell LE; Olbe L; Wängberg B; Nilsson O; Ahlman H
Br J Cancer; 1999 Jun; 80(8):1259-61. PubMed ID: 10376980
[TBL] [Abstract][Full Text] [Related]
15. Typical and atypical carcinoid tumours: analysis of the experience of the Spanish Multi-centric Study of Neuroendocrine Tumours of the Lung.
García-Yuste M; Matilla JM; Cueto A; Paniagua JM; Ramos G; Cañizares MA; Muguruza I;
Eur J Cardiothorac Surg; 2007 Feb; 31(2):192-7. PubMed ID: 17196822
[TBL] [Abstract][Full Text] [Related]
16. Prospective study of the value of serum chromogranin A or serum gastrin levels in the assessment of the presence, extent, or growth of gastrinomas.
Goebel SU; Serrano J; Yu F; Gibril F; Venzon DJ; Jensen RT
Cancer; 1999 Apr; 85(7):1470-83. PubMed ID: 10193936
[TBL] [Abstract][Full Text] [Related]
17. Midgut carcinoid tumours: surgical treatment and prognosis.
Kerström G; Hellman P; Hessman O
Best Pract Res Clin Gastroenterol; 2005 Oct; 19(5):717-28. PubMed ID: 16253896
[TBL] [Abstract][Full Text] [Related]
18. Operative resection of primary carcinoid neoplasms in patients with liver metastases yields significantly better survival.
Givi B; Pommier SJ; Thompson AK; Diggs BS; Pommier RF
Surgery; 2006 Dec; 140(6):891-7; discussion 897-8. PubMed ID: 17188135
[TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal carcinoids. Prognosis and survival.
Caprotti R; Angelini C; Mussi C; Romano F; Sartori P; Scaini A; Muselli P; Uggeri F
Minerva Chir; 2003 Aug; 58(4):523-28,529-32. PubMed ID: 14603164
[TBL] [Abstract][Full Text] [Related]
20. Is adjuvant therapy with streptozotocin and 5-fluorouracil useful after resection of liver metastases from digestive endocrine tumors?
Maire F; Hammel P; Kianmanesh R; Hentic O; Couvelard A; Rebours V; Zappa M; Raymond E; Sauvanet A; Louvet C; Lévy P; Belghiti J; Ruszniewski P
Surgery; 2009 Jan; 145(1):69-75. PubMed ID: 19081477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]